Literature DB >> 4003727

Prevalence of bronchial asthma and respiratory symptoms in schoolchildren in Oslo.

I J Skarpaas, A Gulsvik.   

Abstract

During the school year 1980-81 a survey questionnaire was carried out among schoolchildren aged 7 to 15 years in Oslo. The survey population comprised 39,162 children attending compulsory primary school. The questionnaire was distributed to a random sample of 1772 children in 81 classes, forms 1 to 9, and the response rate was 95%. The prevalence of physician-diagnosis of current and cumulative asthma was 1.6% and 3.1%, respectively. Of those with current asthma 68% used asthma drugs regularly. Occasional wheezing and attacks of breathlessness were reported by 9% and 4%, respectively. Wheezing and breathlessness on exposure to pollen (4.5%), animals (3.1%) and exercise (5.5%) was reported more frequently than physician-diagnosis of asthma. The cumulative prevalence of either hay fever, eczema, urticaria or asthma was 17%. More boys than girls under the age of 12 had a physician-diagnosis of asthma.

Entities:  

Mesh:

Year:  1985        PMID: 4003727     DOI: 10.1111/j.1398-9995.1985.tb00235.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

Review 1.  [Hypothesis of the changes in the frequency of asthma].

Authors:  S Daneault; C Infante-Rivard
Journal:  CMAJ       Date:  1988-08-15       Impact factor: 8.262

2.  Physical activity affects the prevalence of reported wheeze.

Authors:  W Nystad; P Nafstad; J R Harris
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 3.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

4.  Increasing risk of asthma without other atopic diseases in school children: a repeated cross-sectional study after 13 years.

Authors:  W Nystad; P Magnus; A Gulsvik
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.